These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17589345)

  • 1. FoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusion.
    Cirocco RE; Carreño MR; Mathew JM; Garcia-Morales RO; Fuller L; Esquenazi V; Ciancio G; Burke GW; Gaynor JJ; Blomberg BB; Rosen A; Kleiner G; Ricordi C; Miller J
    Transplantation; 2007 Jun; 83(12):1611-9. PubMed ID: 17589345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.
    Ciancio G; Burke GW; Garcia-Morales R; Suzart K; Rosen A; Ricordi C; Kenyon NS; Mathew JM; Tzakis AG; Esquenazi V; Miller J
    Transplantation; 2002 Aug; 74(4):488-96. PubMed ID: 12352907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor bone marrow infusion in deceased and living donor renal transplantation.
    Ciancio G; Burke GW; Moon J; Garcia-Morales R; Rosen A; Esquenazi V; Mathew J; Jin Y; Miller J
    Yonsei Med J; 2004 Dec; 45(6):998-1003. PubMed ID: 15627290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.
    Mathew JM; Garcia-Morales RO; Carreno M; Jin Y; Fuller L; Blomberg B; Cirocco R; Burke GW; Ciancio G; Ricordi C; Esquenazi V; Tzakis AG; Miller J
    Transpl Immunol; 2003; 11(3-4):307-21. PubMed ID: 12967784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
    Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
    Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-year clinical effect of donor bone marrow infusions in renal transplant patients.
    Ciancio G; Miller J; Garcia-Morales RO; Carreno M; Burke GW; Roth D; Kupin W; Tzakis AG; Ricordi C; Rosen A; Fuller L; Esquenazi V
    Transplantation; 2001 Apr; 71(7):827-35. PubMed ID: 11349712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome.
    Daniel V; Naujokat C; Sadeghi M; Weimer R; Renner F; Yildiz S; Opelz G
    Transpl Int; 2008 Jul; 21(7):646-60. PubMed ID: 18298587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion.
    Ranjbar M; Solgi G; Mohammadnia M; Nikbin B; Pourmand G; Ansaripour B; Amirzargar A
    Clin Exp Nephrol; 2012 Aug; 16(4):636-46. PubMed ID: 22314659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
    Chu ZQ; Ji Q
    Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Difference between FOXP3 gene expressions in donor grafts with or without acute graft-versus-host disease].
    Wang ZD; Feng SZ; Zhou SY; Wang M; Zhou Z; Zhai WJ; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1215-20. PubMed ID: 17204197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses.
    Mathew JM; Garcia-Morales R; Fuller L; Rosen A; Ciancio G; Burke GW; Carreno M; Temple D; Tzakis AG; Ricordi C; Miller J; Esquenazi V
    Transplantation; 2000 Dec; 70(12):1675-82. PubMed ID: 11152096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
    Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
    Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance of different types of CD4(+)Foxp3(+) T cells in renal transplant recipients.
    Hu K; Zhou H; Zheng G; Wang G; Fu Y; Jiang Y
    Immunol Invest; 2014; 43(8):838-50. PubMed ID: 24927378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cells.
    Carreno MR; Fuller L; Mathew JM; Ciancio G; Burke GW; Esquenazi V; Ricordi C; Tzakis AG; Miller J
    Hum Immunol; 2003 Jan; 64(1):21-30. PubMed ID: 12507811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Messenger RNA for FOXP3 in the urine of renal-allograft recipients.
    Muthukumar T; Dadhania D; Ding R; Snopkowski C; Naqvi R; Lee JB; Hartono C; Li B; Sharma VK; Seshan SV; Kapur S; Hancock WW; Schwartz JE; Suthanthiran M
    N Engl J Med; 2005 Dec; 353(22):2342-51. PubMed ID: 16319383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased circulating CD4+CD25highFoxp3+ T cells during acute rejection in liver transplant patients.
    He Q; Fan H; Li JQ; Qi HZ
    Transplant Proc; 2011 Jun; 43(5):1696-700. PubMed ID: 21693260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.